The global mortality rates of malignant neoplasms in the trachea, bronchus, or lung vary significantly by country. As of 2023, higher mortality rates are evident in Hungary and Greece, while lower rates are observed in countries like Mexico and Costa Rica. Recent data show a declining trend in countries such as the USA, Switzerland, and Argentina, indicating progress in mitigating risk factors or enhancing healthcare. Meanwhile, countries like Bulgaria and South Korea have experienced slight increases.
Future trends to watch include the impact of advancements in early detection and treatment, as well as changes in smoking habits and air quality. Continued emphasis on smoking cessation programs and improving healthcare infrastructure could alter these mortality patterns globally.
Top countries in Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Male Deaths) Per Hundred Thousand Men | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Hungary | 106.2 | 2023 | -0.75% | -1.46% | View data |
| 2 | 2 Greece | 105.3 | 2023 | +0.57% | -0.15% | View data |
| 3 | 3 Croatia | 99.7 | 2023 | +0.2% | -0.95% | View data |
| 4 | 4 Japan | 87.9 | 2023 | +0.34% | +0.63% | View data |
| 5 | 5 Latvia | 81.1 | 2023 | -0.25% | +0.6% | View data |
| 6 | 6 Bulgaria | 78.6 | 2023 | +0.64% | +1.08% | View data |
| 7 | 7 Poland | 73.8 | 2023 | -1.99% | -2.79% | View data |
| 8 | 8 Slovenia | 72.7 | 2023 | 0% | +0.11% | View data |
| 9 | 9 Estonia | 72.1 | 2023 | -1.1% | -2.3% | View data |
| 10 | 10 Portugal | 70.7 | 2023 | +1% | +0.96% | View data |
